According to SPER Market Research, the proteomics market is estimated to reach USD 92.55 billion by 2030 with a CAGR of 15.2%.
The rising prevalence of infectious diseases, cancers, and genetic disorders is driving the growth of this market.
Proteomics is a large-scale study to analyze proteins. A proteome is a set of proteins that are synthesized by an organism. The study of proteomes helps in identifying the composition, activity, structure, and stresses that an organism goes through. This study can be utilized in developing treatments for genetic disorders, cancers, and viruses.
Nanotechnology has been applied to proteomics to develop nanoproteomic techniques. This technique is utilized to develop phosphoproteomics, nanostructured surfaces for protein separation, and other techniques for the detection of biomarker proteins.
The immunoassay reagents market is the largest reagent segment by share in this market. The large share of this segment is mainly ascribed to a wide range of reagents available, reliability specificity, and fast detection. North America dominated the market by regional segmentation owing to increasing funding and investments, rising focus on the high quality of research proceedings, rising demand for personalizedc medicines, and presence of key market players in this market in North America.
The global proteomics market study provides market data by the competitive landscape, revenue analysis, market segments, and detailed analysis of key market players such as Agilent Technologies, Inc., Applied Biomics, Inc., Biognosys AG, Biomax Informatics AG, Bioproximity, Bio-Rad Laboratories, Inc., Bruker Corporation, Creative Proteomics, Danaher Corporation, Eurofins Scientific, Fios Genomics Ltd., GE Healthcare, GENEWIZ, HORIBA, Ltd., Illumina, Inc., Integrated Proteomics Applications, Luminex Corporation, Merck KGaA, MRM Proteomics Inc., MS Bioworks LLC, PerkinElmer Inc., Poochon Scientific, LLC, Promega Corporation, Proteome Factory AG, QIAGEN Bioinformatics.
SPER Market Research study aims to provide market dynamics, demand, and supply with a yearly forecast to 2030. This report provides data for growth estimates and forecasts for technology segments- Spectroscopy (Mass Spectroscopy, NMR Spectroscopy, CD Spectroscopy), Chromatography (HPLC, Ion Chromatography, Affinity Chromatography, Supercritical Fluid Chromatography), Electrophoresis (Gel Electrophoresis, Capillary Electrophoresis), Protein Microarrays (Biochips [Lab-on-Chips, Protein Chips], Micrparray Instruments [Integrated Systems, Microarray Scanners, Arrayers]), X – Ray Crystallography, Surface Plasmon Resonance, Protein Fractionation; for reagents segment- Immunoassay Reagents, Spectroscopy Reagents, Chromatography Reagents, Protein Microarray Reagents, X – Ray Crystallography Reagents, Electrophoresis Reagents, Protein Fractionation Reagents; for software & segment segment- Core Proteomics Services (Protein Identification Services, Protein Characterization Services, Quantitative Proteomic Services, Protein Purification Services, Protein Sequencing Services, Custom Assay Services), Bioinformatics Software & Services (Bioinformatics Software, Bioinformatics Tools, Bioinformatics Databases); for application segment- Clinical Diagnostics (Cancer, Infectious Diseases, Diabetes, Neurological Disorders, Immune Diseases, Cardiovascular Diseases, Other Clinical Diagnostic Applications), Drug Discovery (Target Discovery, Lead Identification, Lead Optimization, Preclinical Studies), Other Application; for end user segment- Hospitals, Clinical Laboratories, Pharmaceutical Companies, Academic Research Laboratories, Other End Users. This report also provides the data for key regional segments of North America, Europe, Asia-Pacific and the Rest of the World.
This study also encompasses various drivers and restraining factors for this market for the forecast period. Various growth opportunities are also discussed in the report.